Clinical Trial Update: Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical Trial [Phase 2]

View source ↗

Summary

A Phase IIa multicentre randomized double-blind trial assessing ambroxol in dementia with Lewy bodies is ongoing or in early stages, with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia with Lewy Bodies

Drugs mentioned

• Ambroxol (Ambroxol)

Snippet

Sponsor: Helse Fonna | Conditions: Dementia With Lewy Bodies | Phase 2 | Status: UNKNOWN